KPIs & Operating Metrics(New)
Growth Metrics

Gsk (GSK) Minority Interest (2016 - 2025)

Historic Minority Interest for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to -$534.2 million.

  • Gsk's Minority Interest rose 2591.67% to -$534.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$534.2 million, marking a year-over-year increase of 2591.67%. This contributed to the annual value of -$747.8 million for FY2024, which is 891.37% down from last year.
  • Gsk's Minority Interest amounted to -$534.2 million in Q3 2025, which was up 2591.67% from -$583.0 million recorded in Q2 2025.
  • In the past 5 years, Gsk's Minority Interest registered a high of $8.7 billion during Q3 2021, and its lowest value of -$775.1 million during Q1 2024.
  • Over the past 5 years, Gsk's median Minority Interest value was -$588.8 million (recorded in 2022), while the average stood at $2.2 billion.
  • Per our database at Business Quant, Gsk's Minority Interest plummeted by 10843.67% in 2023 and then soared by 2591.67% in 2025.
  • Over the past 5 years, Gsk's Minority Interest (Quarter) stood at $8.5 billion in 2021, then crashed by 106.95% to -$588.8 million in 2022, then dropped by 16.36% to -$685.1 million in 2023, then dropped by 9.59% to -$750.8 million in 2024, then grew by 28.85% to -$534.2 million in 2025.
  • Its Minority Interest was -$534.2 million in Q3 2025, compared to -$583.0 million in Q2 2025 and -$633.5 million in Q1 2025.